Masashi Mukoyama

21.0k total citations · 6 hit papers
259 papers, 15.3k citations indexed

About

Masashi Mukoyama is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Nephrology. According to data from OpenAlex, Masashi Mukoyama has authored 259 papers receiving a total of 15.3k indexed citations (citations by other indexed papers that have themselves been cited), including 92 papers in Cardiology and Cardiovascular Medicine, 86 papers in Molecular Biology and 63 papers in Nephrology. Recurrent topics in Masashi Mukoyama's work include Heart Failure Treatment and Management (48 papers), Renal Diseases and Glomerulopathies (23 papers) and Hormonal Regulation and Hypertension (22 papers). Masashi Mukoyama is often cited by papers focused on Heart Failure Treatment and Management (48 papers), Renal Diseases and Glomerulopathies (23 papers) and Hormonal Regulation and Hypertension (22 papers). Masashi Mukoyama collaborates with scholars based in Japan, United States and United Kingdom. Masashi Mukoyama's co-authors include Kazuwa Nakao, Michihisa Jougasaki, Yoshihiro Ogawa, Hirofumi Yasue, Yoshihiko Saito, Kiminori Hosoda, Gotaro Shirakami, Akira Sugawara, Kiyoshi Mori and Hiroo Imura and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Masashi Mukoyama

247 papers receiving 14.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.

1991 1.1k citations Masashi Mukoyama, Kazuwa Nakao et al. Journal of Clinical Investigation profile →
Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.

1994 1.1k citations Hirofumi Yasue, Michihiro Yoshimura et al. profile →
Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury

2005 746 citations Kiyoshi Mori, Takayoshi Suganami et al. Journal of Clinical Investigation profile →
Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors.

1993 657 citations Masashi Mukoyama et al. profile →
Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide.

1992 634 citations Sachie Suga, Kazuwa Nakao et al. profile →
Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure.

1993 519 citations Michihiro Yoshimura, Hirofumi Yasue et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Masashi Mukoyama Japan	56	8.0k	4.5k	2.3k	2.2k	1.8k	259	15.3k
Masahiko Kurabayashi Japan	62	5.3k 0.7×	5.8k 1.3×	2.0k 0.9×	3.4k 1.6×	1.9k 1.1×	572	16.9k
Hermann Haller Germany	64	3.4k 0.4×	4.7k 1.0×	2.3k 1.0×	2.1k 1.0×	2.0k 1.1×	307	14.5k
Yoshihiko Saito Japan	69	11.7k 1.5×	5.0k 1.1×	3.0k 1.3×	1.4k 0.6×	2.8k 1.6×	493	20.3k
Javier Dı́ez Spain	76	12.0k 1.5×	4.7k 1.0×	1.5k 0.7×	930 0.4×	2.2k 1.2×	407	19.8k
Jitsuo Higaki Japan	62	5.4k 0.7×	3.4k 0.8×	1.3k 0.6×	668 0.3×	1.5k 0.9×	422	12.7k
Douglas E. Vaughan United States	70	6.5k 0.8×	4.0k 0.9×	1.8k 0.8×	612 0.3×	1.9k 1.1×	229	17.0k
Daniel R. Meldrum United States	64	3.1k 0.4×	3.6k 0.8×	2.6k 1.2×	996 0.5×	1.1k 0.6×	264	14.3k
Kimio Tomita Japan	46	2.7k 0.3×	3.5k 0.8×	2.3k 1.0×	3.2k 1.5×	1.7k 0.9×	192	11.3k
Oscar A. Carretero United States	68	6.6k 0.8×	4.4k 1.0×	1.1k 0.5×	890 0.4×	3.2k 1.8×	313	14.1k
Hiroshi Itoh Japan	74	6.8k 0.9×	9.2k 2.0×	2.5k 1.1×	1.5k 0.7×	3.9k 2.2×	609	22.7k

Countries citing papers authored by Masashi Mukoyama

Since Specialization

Citations

This map shows the geographic impact of Masashi Mukoyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masashi Mukoyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masashi Mukoyama more than expected).

Fields of papers citing papers by Masashi Mukoyama

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masashi Mukoyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masashi Mukoyama. The network helps show where Masashi Mukoyama may publish in the future.

Co-authorship network of co-authors of Masashi Mukoyama

This figure shows the co-authorship network connecting the top 25 collaborators of Masashi Mukoyama. A scholar is included among the top collaborators of Masashi Mukoyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masashi Mukoyama. Masashi Mukoyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Yang, Yukun Guan, Dechun Feng, et al.. (2025). Infiltrating macrophages replace Kupffer cells and play diverse roles in severe alcohol-associated hepatitis. Cellular and Molecular Immunology. 22(10). 1262–1275.

Yamamoto, Tetsuya, Masato Kasahara, Kenji Ueshima, et al.. (2024). Multicenter randomized controlled trial of intensive uric acid lowering therapy for CKD patients with hyperuricemia: TARGET-UA. Clinical and Experimental Nephrology. 28(8). 764–772. 3 indexed citations

Kuwabara, Takashige, Teruhiko Mizumoto, Takeshi Matsubara, et al.. (2024). SUrvey of renal Biopsy registry database and Anticancer dRUg therapy in Japan (SUBARU-J study). Clinical Kidney Journal. 17(12). sfae327–sfae327. 3 indexed citations

Yasuoka, Yukiko, Yuichiro Izumi, Takashi Fukuyama, et al.. (2024). Tubular Endogenous Erythropoietin Protects Renal Function against Ischemic Reperfusion Injury. International Journal of Molecular Sciences. 25(2). 1223–1223. 1 indexed citations

Ishii, Akira, Hiroyuki Yamada, Keita Mori, et al.. (2023). Sacubitril/valsartan ameliorates renal tubulointerstitial injury through increasing renal plasma flow in a mouse model of type 2 diabetes with aldosterone excess. Nephrology Dialysis Transplantation. 38(11). 2517–2527. 11 indexed citations

Narita, Yuki, Hirofumi Jono, Yutaka Kakizoe, et al.. (2023). Suppression of Indoxyl Sulfate Accumulation Reduces Renal Fibrosis in Sulfotransferase 1a1-Deficient Mice. International Journal of Molecular Sciences. 24(14). 11329–11329. 9 indexed citations

Kakizoe, Yutaka, Miyuki Nakagawa, Yuki Narita, et al.. (2023). A Serine Protease Inhibitor, Camostat Mesilate, Suppresses Urinary Plasmin Activity and Alleviates Hypertension and Podocyte Injury in Dahl Salt-Sensitive Rats. International Journal of Molecular Sciences. 24(21). 15743–15743. 1 indexed citations

Tamura, Takeshi, Takahiro Kodama, Katsuhiko Sato, et al.. (2021). Dysregulation of PI3K and Hippo signaling pathways synergistically induces chronic pancreatitis via CTGF upregulation. Journal of Clinical Investigation. 131(13). 23 indexed citations

Morinaga, Jun, Hironori Nakagami, Hiroki Hayashi, et al.. (2021). Vaccine targeting ANGPTL3 ameliorates dyslipidemia and associated diseases in mouse models of obese dyslipidemia and familial hypercholesterolemia. Cell Reports Medicine. 2(11). 100446–100446. 29 indexed citations

10.

Fukuyama, Takashi, Yuichiro Izumi, Tetsuro Yamashita, et al.. (2020). Differentiation of endogenous erythropoietin and exogenous ESAs by Western blotting. Heliyon. 6(11). e05389–e05389. 5 indexed citations

11.

Yasuoka, Yukiko, Takashi Fukuyama, Yuichiro Izumi, et al.. (2020). Erythropoietin production by the kidney and the liver in response to severe hypoxia evaluated by Western blotting with deglycosylation. Physiological Reports. 8(12). e14485–e14485. 13 indexed citations

12.

Makino, Yuki, Hayato Hikita, Takahiro Kodama, et al.. (2018). CTGF Mediates Tumor–Stroma Interactions between Hepatoma Cells and Hepatic Stellate Cells to Accelerate HCC Progression. Cancer Research. 78(17). 4902–4914. 93 indexed citations

13.

Sharmin, Sazia, Atsuhiro Taguchi, Yusuke Kaku, et al.. (2015). Human Induced Pluripotent Stem Cell–Derived Podocytes Mature into Vascularized Glomeruli upon Experimental Transplantation. Journal of the American Society of Nephrology. 27(6). 1778–1791. 162 indexed citations

14.

Nagae, Tetsuya, Masashi Mukoyama, Akira Sugawara, et al.. (2000). Rat Receptor-Activity-Modifying Proteins (RAMPs) for Adrenomedullin/CGRP Receptor: Cloning and Upregulation in Obstructive Nephropathy. Biochemical and Biophysical Research Communications. 270(1). 89–93. 98 indexed citations

15.

Itoh, Hiroaki, Norimasa Sagawa, Masaaki Hasegawa, et al.. (1993). Brain Natriuretic Peptide Levels in the Umbilical Venous Plasma Are Elevated in Fetal Distress. Neonatology. 64(1). 18–25. 27 indexed citations

16.

Mukoyama, Masashi, Kazuwa Nakao, Kenji Obata, et al.. (1991). Augmented secretion of brain natriuretic peptide in acute myocardial infarction. Biochemical and Biophysical Research Communications. 180(1). 431–436. 90 indexed citations

17.

Mukoyama, Masashi, Kazuwa Nakao, Kiminori Hosoda, et al.. (1991). Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.. Journal of Clinical Investigation. 87(4). 1402–1412. 1121 indexed citations breakdown →

18.

Saito, Yumi, Takashi Yamada, Hiroaki Itoh, et al.. (1989). PLASMA ENDOTHELIN-1-LIKE IMMUNOREACTIVITY LEVEL (ET-1-LI) IN HEALTHY-SUBJECTS AND PATIENTS WITH HYPERTENSION. Hypertension. 14(3). 335–336. 2 indexed citations

19.

Sugawara, Akira, Kazuwa Nakao, Narito Morii, et al.. (1988). Synthesis of atrial natriuretic polypeptide in human failing hearts. Evidence for altered processing of atrial natriuretic polypeptide precursor and augmented synthesis of beta-human ANP.. Journal of Clinical Investigation. 81(6). 1962–1970. 90 indexed citations

20.

Saito, Yoshihiko, Kazuwa Nakao, Narito Morii, et al.. (1987). -416- EFFECTS OF BAY K 8644, A VOLTAGE-SENSITIVE CALCIUM CHANNEL AGONIST, ON SECRETION OF ATRIAL NATRIURETIC POLYPEPTIDE FROM ISOLATED RAT HEARTS. Japanese Circulation Journal-english Edition. 51(8). 903–904.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact